[1]王晓玮,陈国芳,徐书杭,等.肾上腺意外瘤的评估与管理[J].国际内分泌代谢杂志,2021,41(02):78-81.[doi:10.3760/cma.j.cn121383-20200622-06058]
　Wang Xiaowei,Chen Guofang,Xu Shuhang,et al.Evaluation and management of adrenal incidentalomas[J].International Journal of Endocrinology and Metabolism,2021,41(02):78-81.[doi:10.3760/cma.j.cn121383-20200622-06058]
点击复制

肾上腺意外瘤的评估与管理()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年02期
页码:
78-81
栏目:
肾上腺疾病专题
出版日期:
2021-03-20

文章信息/Info

Title:
Evaluation and management of adrenal incidentalomas
作者:
王晓玮1; 2; 陈国芳1; 徐书杭1; 刘超1
1南京中医药大学附属中西医结合医院内分泌科 210028; 2南京中医药大学 210023
Author(s):
Wang Xiaowei1; 2;  Chen Guofang1;  Xu Shuhang1;  Liu Chao1.
1Department of Endocrinology and Metabolism, Affiliated Hospital of Integration of Chinese and Western Medicine in Jiangsu Province, Nanjing 210028,China; 2Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China
关键词:
肾上腺意外瘤;  影像学评估;  生化评估
Keywords:
Adrenal incidentaloma;  Imaging exams;  Biochemical tests
DOI:
10.3760/cma.j.cn121383-20200622-06058
摘要:
肾上腺意外瘤(adrenal incidentalomas,AI)的检出率日渐增高。初诊AI时需要结合影像学检查和生化检测评估其良、恶性和有无内分泌功能。恶性或功能性AI患者行手术治疗,未行手术治疗的患者随访观察。规范的AI管理流程是AI正确诊断和治疗的保障。
Abstract:
The identification of adrenal incidentalomas(AI)has been increased recently. Imaging exams and biochemical tests should be combined to evaluate the nature and endocrinological level of AI. Functional or malignant AI requires surgical intervention while there needs to be an appropriate plan for follow-up if surgical intervention is not planned. A standardized algorithm to approach the workup of patients with adrenal incidentaloma will ensure proper diagnosis and treatment.

参考文献/References:

[1] Fassnacht M,Arlt W,Bancos I,et al. Management of adrenal incidentalomas:European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors[J].Eur J Endocrinol,2016,175(2):G1-G34.DOI:10.1530/EJE-16-0467.
[2] Grossman A,Koren R,Tirosh A,et al. Prevalence and clinical characteristics of adrenal incidentalomas in potential kidney donors[J].Endocr Res,2016,41(2):98-102.DOI:10.3109/07435800.2015.1076455.
[3] Dinnes J,Bancos I,Di Ruffano LF,et al. Management of endocrine disease:imaging for the diagnosis of malignancy in incidentally discovered adrenal masses:a systematic review and meta-analysis[J].Eur J Endocrinol,2016,175(2):R51-R64.DOI:10.1530/EJE-16-0461.
[4] NIH state-of-the-science statement on management of the clinically inapparent adrenal mass("incidentaloma")[J].NIH Consens State Sci Statements,2002,19(2):1-25.
[5] Mantero F,Terzolo M,Arnaldi G,et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology[J].J Clin Endocrinol Metab,2000,85(2):637-644.DOI:10.1210/jcem.85.2.6372.
[6] Bednarczuk T,Bolanowski M,Sworczak K,et al. Adrenal incidentaloma in adults-management recommendations by the Polish Society of Endocrinology[J].Endokrynol Pol,2016,67(2):234-258.DOI:10.5603/EP.a2016.0039.
[7] Anoj A,陈克敏. 肾上腺偶发瘤的影像学诊断与治疗进展[J].诊断学理论与实践,2015,14(5):473-478.DOI:10.16150/j.1671-2870.2015.05.019.
[8] Merkle EM,Schindera ST. MR imaging of the adrenal glands:1.5T versus 3T[J].Magn Reson Imaging Clin N Am,2007,15(3):365-372,vii.DOI:10.1016/j.mric.2007.06.008.
[9] Kim SJ,Lee SW,Pak K,et al. Diagnostic accuracy of 18F-FDG PET or PET/CT for the characterization of adrenal masses:a systematic review and meta-analysis[J].Br J Radiol,2018,91(1086):20170520.DOI:10.1259/bjr.20170520.
[10] Cistaro A,Niccoli Asabella A,Coppolino P,et al. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies-a multicenter experience[J].Hell J Nucl Med,2015,18(2):97-102.DOI:10.1967/s002449910202.
[11] Akku G,Güney IB,Ok F,et al. Diagnostic efficacy of 18F-FDG PET/CT in patients with adrenal incidentaloma[J].Endocr Connect,2019,8(7):838-845.DOI:10.1530/EC-19-0204.
[12] Di Dalmazi G,Pasquali R,Beuschlein F,et al. Subclinical hypercortisolism:a state,a syndrome,or a disease?[J].Eur J Endocrinol,2015,173(4):M61-M71.DOI:10.1530/EJE-15-0272.
[13] Elhassan YS,Alahdab F,Prete A,et al. Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess:a systematic review and meta-analysis[J].Ann Intern Med,2019,171(2):107-116.DOI:10.7326/M18-3630.
[14] Barbot M,Zilio M,Scaroni C. Cushing's syndrome:overview of clinical presentation,diagnostic tools and complications[J].Best Pract Res Clin Endocrinol Metab,2020,34(2):101380.DOI:10.1016/j.beem.2020.101380.
[15] 张文婧,朱科盈,张燕,等. 亚临床库欣病两例报道及文献复习[J].国际内分泌代谢杂志,2019,39(4):282-286,288.DOI:10.3760/cma.j.issn.1673-4157.2019.04.017.
[16] Dietrich CF,Correas JM,Dong Y,et al. WFUMB position paper on the management incidental findings:adrenal incidentaloma[J].Ultrasonography,2020,39(1):11-21.DOI:10.14366/usg.19029.
[17] Harvey AM. Hyperaldosteronism:diagnosis,lateralization,and treatment[J].Surg Clin North Am,2014,94(3):643-656.DOI:10.1016/j.suc.2014.02.007.
[18] Falhammar H,Kjellman M,Calissendorff J. Initial clinical presentation and spectrum of pheochromocytoma:a study of 94 cases from a single center[J].Endocr Connect,2018,7(1):186-192.DOI:10.1530/EC-17-0321.
[19] Else T,Kim AC,Sabolch A,et al. Adrenocortical carcinoma[J].Endocr Rev,2014,35(2):282-326.DOI:10.1210/er.2013-1029.
[20] Terzolo M,Reimondo G. Insights on the natural history of adrenal incidentalomas[J].Ann Intern Med,2019,171(2):135-136.DOI:10.7326/M19-1482.
[21] Tasaki M,Kasahara T,Takizawa I,et al. Limited significance of repeated long-term radiological and hormonal examination in nonfunctioning adrenal incidentalomas[J].Int Braz J Urol,2019,45(3):503-513.DOI:10.1590/S1677-5538.IBJU.2018.0235.

备注/Memo

备注/Memo:
通信作者:徐书杭,Email: shuhangxu@163.com; 刘超,Email:liuchao@nfmcn.com
更新日期/Last Update: 2021-03-20